These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7533342)

  • 21. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
    Okada N; Tanaka H; Takizawa H; Okada H
    J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
    Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteins containing an uncleaved signal for glycophosphatidylinositol membrane anchor attachment are retained in a post-ER compartment.
    Moran P; Caras IW
    J Cell Biol; 1992 Nov; 119(4):763-72. PubMed ID: 1385443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
    Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
    Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UMC, another Cromer-related blood group antigen.
    Daniels GL; Okubo Y; Yamaguchi H; Seno T; Ikuta M
    Transfusion; 1989; 29(9):794-7. PubMed ID: 2480010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 28. Decay-accelerating-factor-deficient erythrocytes during the long-term clinical course of patients with paroxysmal nocturnal hemoglobinuria.
    Mahbub B; Nishimura J; Kitani T; Kitano K
    Acta Haematol; 1995; 93(2-4):91-7. PubMed ID: 7543722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
    Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
    J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
    Sayama K; Shiraishi S; Miki Y
    Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
    Taylor CT; Johnson PM
    Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.
    Manchester M; Gairin JE; Patterson JB; Alvarez J; Liszewski MK; Eto DS; Atkinson JP; Oldstone MB
    Virology; 1997 Jun; 233(1):174-84. PubMed ID: 9201227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

  • 35. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
    Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
    J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
    van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
    Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
    [No Abstract]   [Full Text] [Related]  

  • 38. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structures and molecular recognition mechanism of leukocyte immunoglobulin-like receptor family].
    Kuroki K; Maenaka K
    Seikagaku; 2011 Aug; 83(8):715-26. PubMed ID: 21942093
    [No Abstract]   [Full Text] [Related]  

  • 40. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.